Actively Recruiting
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
Led by Oregon Health and Science University · Updated on 2025-10-16
32
Participants Needed
1
Research Sites
283 weeks
Total Duration
On this page
Sponsors
O
Oregon Health and Science University
Lead Sponsor
B
Boston Scientific Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Morton's neuroma is a benign thickening involving the plantar interdigital nerve, most common in middle aged women. Morton's neuroma is one of the most frequent diagnoses seen in the investigators podiatry clinic and is difficult to treat. These lesions cause a burning or shooting pain that can radiate to the toes, or an aching pain in the ball of the foot. The pain is exacerbated with activity and certain footwear greatly limits activity in the involved patient population. Morton's neuroma is first treated conservatively with orthotics. Patients may require further interventions such as steroid injections. The literature reports only a 30% long term resolution of pain with the steroid. Surgical resection has a reported 51-85% success rate with 14-21% rate of complication; recurrent pain, numbness/loss of sensation, and subsequent stump neuromas. Cryoablation is well known to be efficacious for neuropathic pain and has recently been shown in two small studies to be safe and efficacious for treatment of Morton's neuroma. The investigators study will compare outcomes of cryoablation to corticosteroid injection in short- and long-term for treatment of Morton's neuroma that have failed conservative therapy.
CONDITIONS
Official Title
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Able to consent and complete questionnaires
- Failed a four-week trial of conservative therapy including orthotics, suitable footwear, or metatarsal pads
- X-ray and ultrasound confirming presence and location of Morton's neuroma and excluding other conditions
You will not qualify if you...
- Unable to follow-up or comply with follow-up schedule
- Contraindications to cryoablation or lidocaine/steroid injection
- Other conditions found on imaging that could explain symptoms
- Unwilling to be randomized to treatment groups
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oregon Health Sciences University
Portland, Oregon, United States, 97239
Actively Recruiting
Research Team
L
Lori L Russell, MSN BSN RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here